Pancreatic ductal adenocarcinoma (PDAC)gemcitabinechemotherapyimmunotherapy
…Background Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with a survival rate under 13%. Treatments …
43articles mentioning diseases
43disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Pancreatic ductal adenocarcinoma (PDAC) ×
Pancreatic ductal adenocarcinoma (PDAC)
This disease is selected. Its supporting articles are shown below.
Articles mentioning Pancreatic ductal adenocarcinoma (PDAC)
43 articles · page 4 of 4pancreatic ductal adenocarcinoma (PDAC)University of California San DiegoThe Jackson LaboratoryPBSCPMV
… in multiple other solid tumors, the five-year survival rate of pancreatic ductal adenocarcinoma (PDAC) remains at approximately 13%. 1 PDAC tumors demonstrate high T-…
pancreatic ductal adenocarcinoma (PDAC)JIB04anti-PD-1 therapyimmunotherapyanti-programmed cell death protein-1 (PD-1) therapy
…und Despite progress in immunotherapy for several solid tumors, pancreatic ductal adenocarcinoma (PDAC) remains largely unresponsive, primarily due to its profoundly i…
pancreatic ductal adenocarcinoma (PDAC)CA199TGF-β
…ants. The role of sCD58 in the tumor immune microenvironment of pancreatic ductal adenocarcinoma (PDAC) is currently unknown.Methods The expression and prognostic role…
pancreatic ductal adenocarcinoma (PDAC)intraductal papillary mucinous neoplasms (IPMNs)
…ous neoplasms (IPMNs), which are bona fide cystic precursors of pancreatic ductal adenocarcinoma (PDAC).Objective We aimed to uncover biochemical and molecular drivers…
Pancreatic ductal adenocarcinoma (PDAC)immunotherapymultiaxis interventionsinterleukin-1β
…Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies, characterized by a p…
pancreatic ductal adenocarcinoma (PDAC)
…broblasts (CAFs) are highly heterogeneous in the progression of pancreatic ductal adenocarcinoma (PDAC) and vasculogenic mimicry (VM) refers to a phenomenon in which c…